Terumo Corporation and Quirem Medical Expand Strategic Alliance, including a global distribution agreement and a future buy-out option

Terumo Corporation and Quirem Medical B.V., a commercial stage Dutch medical technology company that focuses on radioembolization, today announced that Terumo will become the exclusive global distributor for the radioembolization solutions developed by Quirem Medical and has furthermore obtained a buy-out option.

Read the official Terumo news statement here

Categories: News